Health Care Innovation
Our MedTech team has a long history of working with health care innovators to introduce cutting-edge products and services, paving the way to new efficiencies and marked improvements in patient outcomes. Through this exposure, we’ve developed a keen understanding of the demands placed on hospital leadership and the innovation needed to maintain competitive positioning in the business and consumer marketplaces.
We keep close tabs on the evolving regulations, including requirements for telehealth and medical marijuana treatment. Drawing on our deep regulatory knowledge, we help traditional health systems and providers undertake new enterprise technology initiatives and execute disciplined implementation plans. We also help medical technology players protect and commercialize their intellectual property assets, develop effective and legally sound go-to-market strategies and forge strategic alliances with the right providers.
Notably, several of our attorneys have advanced technical degrees and prior experience working for pharmaceutical companies and major research institutions. We integrate skill and savvy across multiple legal disciplines to help life sciences companies and other industry disruptors overcome barriers to innovation while remaining responsive to regulators and consumers. We aim to be true innovators in how we support our clients, driving meaningful difference through creatively conceived and well-executed solutions.
Sub-Industry Team Contact
What’s in the 86 COBRA Subsidy Q&As Released by the IRS?
June 15, 2021 | Publications
On May 18, 2021, the Internal Revenue Service (IRS) released Notice 2021-31 (“Notice”), a set of...
OSHA Issues New COVID-19 Safety Rules for Healthcare Sector and New Guidelines for All Industries
June 11, 2021 | Blogs
On June 10, 2021, the Department of Labor’s (DOL) Occupational Safety and Health Administration (O...
Third Party Indemnity Claims: What Health Care Providers Need to Know
June 9, 2021 | Blogs
A recent case from the Indiana Court of Appeals highlights the parameters of Indiana’s Medical Mal...
FDA Reverses Exemption of Seven Class I Gloves from 510(k) Premarket Notification Process
May 19, 2021 | Blogs
On April 16, 2021, the Federal Drug Administration (FDA) issued two notices in reaction to the Janua...
Ohio Expands Access to Medical Marijuana Dispensary Licenses
April 22, 2021 | Blogs
On April 19, 2021, the State of Ohio Board of Pharmacy approved increasing the number of medical mar...
Key Definitions for New Stark Law Exceptions and Anti-Kickback Statute Safe Harbors for Value-Based...
March 16, 2021 | Blogs
As the health care industry continues to integrate, providers and health care professionals are chal...